Prevalence of multimorbidity and polypharmacy among adults and older adults: a systematic review

Overview of attention for article published in The Lancet Healthy Longevity, March 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news: 12 news outlets
blogs: 1 blog

twitter: 30 X users
guideline: 1 clinical guideline source

Readers on

mendeley: 476 Mendeley

So far, Altmetric has seen 30 X posts from 30 X users, with an upper bound of 65,900 followers.

This systematic review found higher prevalence estimates of multimorbidity and polypharmacy in clinical settings vs community settings among adults and older adults across 30+ countries. https://t.co/fePWze5N8N @LancetLongevity

RT @LancetLongevity: Prevalence of multimorbidity and polypharmacy among adults and older adults: a systematic review by Kathryn Nicholson…

In older adult samples, the prevalence of multimorbidity ranged from 4·8% to 93·1%, while the prevalence of polypharmacy ranged from 2·6% to 86·6%.

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 26 additional X posts.